Drugs and vascular dementia |
| |
Authors: | Allain Hervé Bentue-Ferrer Danièle Tribut Olivier Pinel Jean-François |
| |
Affiliation: | Laboratory of Pharmacology, Faculty of Medicine, University of Rennes I, 2 avenue du Pr. Leon Bernard, CS 34317, F-35043 Rennes cedex, France. Harve.Allain@univ-rennes1.fr |
| |
Abstract: | Between 20 and 35% of all dementias are vascular in origin, their etiology is due to cerebrovascular disease and the risk factors are known (e.g. hypertension, diabetes, smoking, or hyperlipidemia). Primary and secondary preventions are the basis of therapeutics. Symptomatic treatment is emerging, notably in the field of cognitive disorders. In that respect, monoamine oxidase inhibitors, and more recently acetylcholinesterase inhibitors, are in the process of being recognized as first-line treatments of established vascular dementia. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|